Citation Tools

Original research
TIGIT is a key inhibitory checkpoint receptor in lymphoma

Download to a citation manager

Cite this article as:
Godfrey J, Chen X, Sunseri N, et al
TIGIT is a key inhibitory checkpoint receptor in lymphoma